
at the venous insertion site (4%) or in the retroperitoneum
(1%). Major neurologic complications, including one fatal
intracranial hemorrhage and one subdural hematoma, occurred in only two patients (0.4%).
A systematic review that included trials of systemic and
locoregional thrombolysis reported higher rates of bleeding among patients treated with thrombolytic agents (RR,
1.73; 95% CI 